NASHVILLE, Tenn.--(BUSINESS WIRE)--Aug. 4, 2005--Caremark Rx, Inc. (NYSE: CMX) today reported diluted earnings per share of $.47 for the second quarter of 2005, $.01 ahead of First Call consensus estimates. The second quarter financial results included $5.9 million of integration and other expenses related to the acquisition of AdvancePCS, which closed in the first quarter of 2004. Excluding these expenses, diluted earnings per share for the second quarter of 2005 also was $.47, a 57% increase from the second quarter of 2004.
